Bacillus Calmette-Guérin Spondylodiscitis after Intravesical BCG Therapy: A Case Report-Reference-Cited by-同舟云学术

Bacillus Calmette-Guérin Spondylodiscitis after Intravesical BCG Therapy: A Case Report

Published:2022-11-27 Issue:6 Volume:6 Page:721-724
ISSN:2432-261X
Container-title:Spine Surgery and Related Research
language:en
Short-container-title:Spine Surg Relat Res

Author:

Kawai Akihito¹,Kawasaki Sachiko¹,Nishimura Tomoko²,Shigematsu Hideki¹,Tanaka Masato¹,Tanaka Yasuhito¹

Affiliation:

1. Department of Orthopaedic Surgery, Nara Medical University

2. Center for Infectious Diseases, Nara Medical University

Publisher

Japanese Society for Spine Surgery and Related Research

Subject

Neurology (clinical),Orthopedics and Sports Medicine,Surgery

Link

https://www.jstage.jst.go.jp/article/ssrr/6/6/6_2022-0009/_pdf

Reference10 articles.

1. 1. Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol. 1976;116 (2):180-3.

2. 2. Pérez-Jacoiste Asín MA, Fernandez-Ruiz M, Lopez-Medrano F, et al. Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature. Medicine. 2014;93 (17):236-54.

3. 3. Cancer Statistics. Cancer Information Service, National Cancer Center, Japan (National Cancer Registry, Ministry of Health, Labour and Welfare). 2021 Jul - [cited 2021 Dec 20]. Available from: https://ganjoho.jp/public/index.html

4. 4. Broekx S, Buelens E. Tuberculous spondylitis following intravesical bcg-instillation in the treatment of transitional cell carcinoma: case report and systematic review. Clin Neurol Neurosurg. 2020;194:105944.

5. 5. Mavrogenis AF, Sakellariou VI, Tsiodras S, et al. Late Mycobacterium bovis spondylitis after intravesical BCG therapy. Joint Bone Spine. 2009;76 (3):296-300.